immatics biotechnologies GmbH
Utility Patents

Last updated:

List of all immatics biotechnologies GmbH patents 366 in total

Status Patent
Grant
Utility: Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers External link
Filling date: 9 Sep 2025 Issue date: 7 Jan 2020
Grant
Utility: T cell receptors and immune therapy using the same External link
Filling date: 9 Sep 2025 Issue date: 7 Jan 2020
Grant
Utility: Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers External link
Filling date: 9 Sep 2025 Issue date: 7 Jan 2020
Grant
Utility: Immunotherapy against melanoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 31 Dec 2019
Grant
Utility: RELAXIN1 derived peptides for use in immunotherapy against various tumors External link
Filling date: 9 Sep 2025 Issue date: 31 Dec 2019
Grant
Utility: Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers External link
Filling date: 9 Sep 2025 Issue date: 24 Dec 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against cancers External link
Filling date: 9 Sep 2025 Issue date: 24 Dec 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 9 Sep 2025 Issue date: 10 Dec 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 3 Dec 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 26 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 26 Nov 2019
Grant
Utility: Immunotherapy against several tumors, such as lung cancer, including NSCLC External link
Filling date: 9 Sep 2025 Issue date: 26 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 26 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 9 Sep 2025 Issue date: 26 Nov 2019
Grant
Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer External link
Filling date: 9 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Immunotherapy against several tumors, such as lung cancer, including NSCLC External link
Filling date: 9 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers External link
Filling date: 9 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 9 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 12 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 9 Sep 2025 Issue date: 12 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 12 Nov 2019
Grant
Utility: Immunotherapy against melanoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 5 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 5 Nov 2019
Grant
Utility: Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 5 Nov 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 5 Nov 2019
Grant
Utility: Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers External link
Filling date: 9 Sep 2025 Issue date: 29 Oct 2019
Grant
Utility: Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) External link
Filling date: 9 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 9 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers External link
Filling date: 9 Sep 2025 Issue date: 15 Oct 2019
Grant
Utility: Immunotherapy against melanoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various cancers External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Immunotherapy against neuronal and brain tumors External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Immunotherapy against melanoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Powerful MHC-class II peptides derived from survivin External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer External link
Filling date: 9 Sep 2025 Issue date: 24 Sep 2019
Grant
Utility: Immunotherapy against neuronal and brain tumors External link
Filling date: 9 Sep 2025 Issue date: 24 Sep 2019
Grant
Utility: Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 3 Sep 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against CLL and other cancers External link
Filling date: 9 Sep 2025 Issue date: 3 Sep 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 9 Sep 2025 Issue date: 27 Aug 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 9 Sep 2025 Issue date: 20 Aug 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various cancers External link
Filling date: 9 Sep 2025 Issue date: 20 Aug 2019
Grant
Utility: Immunotherapy against melanoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 20 Aug 2019
Grant
Utility: Immunotherapy against melanoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 20 Aug 2019

Showing 300 to 350 of 366 patents.